HOME >> MEDICINE >> NEWS
DDW Studies Present Evidence That Thalomid (Thalidomide) Is Active In Treating Crohn's Disease

ORLANDO, FL, May 19, 1999 -- Researchers investigating the use of THALOMIDR (thalidomide) to treat Crohn's disease today announced preliminary findings from a pilot study at the annual Digestive Disease WeekR meeting in Orlando, FL.

Lead investigator, Eric A. Vasiliauskas, M.D., associate clinical director of the Inflammatory Bowel Disease Center at Cedar's Sinai, Los Angeles reported findings from a pilot study of 12 patients at the Center. All patients had chronic, steroid-dependent or unresponsive Crohn's disease, an inflammatory disease of the intestinal tract.

According to Dr. Vasiliauskas, while all study participants felt better on the drug, two-thirds of the patients treated with THALOMID experienced a "significant improvement in their condition," as measured by the Crohn's Disease Activity Index (CDAI). The most common side effects reported were drowsiness and transient peripheral neuropathy. Celgene (NASDAQ: CELG) Corporation's THALOMID (thalidomide) was recently awarded orphan drug designation by the U.S. Food and Drug Administration (FDA).

"Although this was a pilot study, we did observe improvements in CDAI in these patients with Crohn's disease, which had been refractory to standard therapies," says Dr. Vasiliauskas. "In addition, these scores were maintained in most patients, even after steroids were tapered. Decreased fistula drainage and fistula closure was also observed in some patients. The data suggest that a Phase III study using thalidomide to treat Crohn's disease, should be conducted."

Dr. Vasiliauskas reported on the pilot study findings of 12 patients treated during a 12-week study with low-dose (50-100 mg per day) THALOMID (thalidomide). The Cedar's Sinai investigative team for this study also included Stephen R. Targan, M.D., director of the Inflammatory Bowel Disease Center.

In addition to this pilot study, other groups of researchers, including European and American investigative teams, are conducting tr
'"/>

Contact: Sandra Van
Sandy@VanCommunications.com
1-800-396-1002
Cedars-Sinai Medical Center
19-May-1999


Page: 1 2

Related medicine news :

1. Studies underscore genetic involvement in nicotine addiction & aggressive hostility
2. Studies address issues of risk and survival in rapidly increasing GI cancers
3. Studies examine coffee drinking and risk of liver and colorectal cancers
4. Studies reveal physicians attitudes on end-of-life care
5. Studies from the November issue of The Archives of Dermatology, a theme issue on facial rejuvenation
6. Studies link obesity to increased frequency of heartburn symptoms; greater risk of esophageal cancer
7. Studies demonstrate positive data in treatment of hepatitis C
8. Studies examine risk factors and potential consequences associated with prehypertension
9. Studies show ACTOS(R) (pioglitazone HCl) has positive effects on various components of dyslipidemia
10. Studies identify risk factors for colon cancer
11. Studies indicate healthy eating may affect cancer development, improve digestive system

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2020)... ... March 21, 2020 , ... The modular construction ... Builders Association (MHBA), have been working with state and federal officials on ways ... for greater use of modular construction to address the nation’s affordable housing crisis ...
(Date:3/22/2020)... ... March 22, 2020 , ... In times ... to be a frivolous luxury. The world’s focus is on practical matters - ... sense of stability and control in chaos. However, it’s during these times that ...
(Date:3/20/2020)... WILMINGTON, Del. (PRWEB) , ... March 21, 2020 ... ... from the healthcare and legal communities together for a day of live discussion ... topics including patient advocacy and ethics, telemedicine, whistleblower laws, the role of boards, ...
(Date:3/19/2020)... ... March 19, 2020 , ... As confirmed cases of COVID-19 rapidly increase in ... “As a global humanitarian organization, Project HOPE’s mandate is always to respond where the ... Rabih Torbay, President and CEO of Project HOPE. “We will be supporting America’s health ...
(Date:3/16/2020)... (PRWEB) , ... March 16, 2020 , ... ... partnership today to deliver testing for Coronavirus SARS-CoV-2 (the virus that causes COVID-19 ... exchange program in the world and serves approximately 100 transplant programs throughout the ...
Breaking Medicine News(10 mins):
(Date:3/27/2020)... ... ... Shady Grove Fertility (SGF) —home to more than 85,000 babies born—now offers new ... consults , thereby minimizing interruptions in access to fertility care during this pandemic and ... been to improve access to care. We’re pleased to be able to offer patients ...
(Date:3/22/2020)... ... March 21, 2020 , ... As the spread of Coronavirus ... of Thoracic Medicine and Surgery, and the Temple Lung Center have taken proactive ... tracking platform and triage/care coordination services. Temple is now enrolling patients, faculty, staff, ...
(Date:3/20/2020)... ... 2020 , ... Despite the presence of the lone star tick, which is ... Mexico are low, and it might be due to the invasive fire ant species. ... Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) before it ...
Breaking Medicine Technology:
Cached News: